- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Colon in Finland
Total 1275 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
Hennepin Healthcare Research InstituteNational Health and Medical Research Council, Australia; National Cancer Institute... and other collaboratorsActive, not recruiting
-
Aadi Bioscience, Inc.RecruitingCancer | Endometrial Cancer | Tumor | Recurrent Endometrial Carcinoma | Endometrioid Endometrial Cancer | Endometrioid TumorUnited States
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
Yale UniversityActive, not recruitingBreast CancerUnited States
-
CairnSurgical, Inc.RecruitingBreast Cancer FemaleUnited States, Canada, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerDenmark, Sweden, Finland, Hungary, Norway, Romania, Russian Federation
-
NewLink Genetics CorporationTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Recurrent | Progression of Non-small Cell Lung CancerUnited States
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan, Finland
-
Actuate Therapeutics Inc.RecruitingNeuroblastoma | Pediatric Cancer | Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor | Refractory Cancer | Refractory Neoplasm | Refractory Tumor | Cancer Pediatric | Neuroblastoma Recurrent | Pediatric Lymphoma | Pediatric MeningiomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Cervical Small Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical CancerUnited States
-
Sanarus Technologies, Inc.RecruitingBreast CancerUnited States
-
Tragara Pharmaceuticals, Inc.Terminated
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Bristol-Myers SquibbCompletedColorectal Cancer (CRC)United States, Argentina, Italy
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage III Vulvar Cancer | Vulvar Squamous Cell Carcinoma | Stage I Vulvar Cancer | Stage II Vulvar CancerUnited States, Canada
-
Elucida OncologyRecruitingOvarian Diseases | Ovarian Neoplasms | Ovarian Cancer | Ovarian Epithelial Cancer | Fallopian Tube Cancer | Endometrial Neoplasms | Endometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Ovarian Carcinoma | Endometrial Adenocarcinoma | Peritoneal Cancer | Endometrioid Adenocarcinoma | Ovarian Adenocarcinoma | Ovarian Serous Adenocarcinoma and other conditionsUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Chroma TherapeuticsTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditionsUnited States
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
Enzon Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Primary Peritoneal Cancer... and other conditionsUnited States
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
Kazia Therapeutics LimitedCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Australia
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
MacroGenicsCompletedMelanoma | Head and Neck Cancer | Non Small Cell Lung Cancer | Urethelial CarcinomaUnited States
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
AstraZenecaOptum, Inc.CompletedEpithelial Ovarian/Fallopian Tube/Primary Peritoneal CancerUnited States, Italy, Spain
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
Avenge Bio, IncTerminatedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Primary Peritoneal Carcinoma | Neoplasm, Ovarian | Adenocarcinoma Ovary | Serous Adenocarcinoma of Ovary | Serous Adenocarcinoma of Primary Peritoneum | High Grade Serous AdenocarcinomaUnited States
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research InstituteActive, not recruiting
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia